LGN Form 4: Gregory Barnes Receives 8,036 Restricted Stock Units
Rhea-AI Filing Summary
Gregory Barnes, Chief Human Resources Officer of Legence Corp. (LGN), was granted 8,036 Restricted Stock Units on 09/15/2025. Each unit converts to one share of Class A common stock at vesting and carries a $0 reported price because it is an equity award rather than an open-market purchase. The RSUs vest in three substantially equal annual installments on each of the first, second and third anniversaries of the award date, generally subject to continued employment through each vesting date. Following the grant, Mr. Barnes is shown as beneficially owning 8,036 shares on a direct basis. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Barnes on 09/15/2025.
Positive
- Equity-based compensation aligns the CHRO's incentives with long-term shareholder value
- Multi-year vesting (three substantially equal annual installments) supports retention through 2028
Negative
- None.
Insights
TL;DR: Routine executive equity grant of 8,036 RSUs to align CHRO incentives with shareholders; immaterial to valuation alone.
The grant of 8,036 restricted stock units to the Chief Human Resources Officer represents standard compensation practice to retain and align senior management with shareholder interests. The award vests over three years in substantially equal installments, which provides multi-year retention potential. The filing reports direct beneficial ownership of 8,036 shares post-grant and a $0 price consistent with RSU grants. Absent further context on total diluted share count or other concurrent grants, this single grant appears routine and not materially dilutive on its own.
TL;DR: Standard restricted stock unit award with time-based vesting; governance implications are typical for executive retention.
The award’s three-year, annually vesting schedule is a conventional time-based retention mechanism and aligns with common governance practices for senior executives. The Form 4 discloses direct ownership and the vesting schedule but does not indicate performance conditions or accelerated vesting provisions. For governance assessment, investors would typically review aggregate executive equity, grant frequency, and potential change-in-control acceleration clauses—none of which are disclosed on this single Form 4.